Analysts’ Opinions Are Mixed on These Healthcare Stocks: Stryker (SYK) and Hologic (HOLX)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Stryker (SYK – Research Report) and Hologic (HOLX – Research Report).
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Stryker (SYK)
Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Stryker today and set a price target of $440.00. The company’s shares closed last Thursday at $354.30.
According to TipRanks.com, Wise is a 2-star analyst with an average return of
Currently, the analyst consensus on Stryker is a Strong Buy with an average price target of $429.26, which is a 20.1% upside from current levels. In a report issued on January 20, RBC Capital also maintained a Buy rating on the stock with a $435.00 price target.
See the top stocks recommended by analysts >>
Hologic (HOLX)
Needham analyst Michael Matson maintained a Hold rating on Hologic today. The company’s shares closed last Thursday at $74.98.
According to TipRanks.com, Matson is a 3-star analyst with an average return of
Currently, the analyst consensus on Hologic is a Hold with an average price target of $77.00, a 2.5% upside from current levels. In a report issued on January 27, TipRanks – OpenAI also downgraded the stock to Hold with a $81.00 price target.
